Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies

Conditions:   B-cell Acute Lymphoblastic Leukemia;   Lymphoma;   Myeloid Leukemia;   Multiple Myeloma;   Hepatoma;   Gastric Cancer;   Pancreatic Cancer;   Mesothelioma;   Colorectal Cancer;   Esophagus Cancer;   Lung Cancer;   Glioma;   Melanoma;   Synovial Sarcoma;   Ovarian Cancer;   Renal Carcinoma
Intervention:   Biological: CAR-T cell immunotherapy
Sponsors:   Shenzhen BinDeBio Ltd.;   The First Affiliated Hospital of Zhengzhou University
Recruiting

https://ift.tt/2OUD6YX